XRAY vs COO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

XRAY

57.2
AI Score
VS
XRAY Wins

COO

44.0
AI Score

Investment Advisor Scores

XRAY

57score
Recommendation
HOLD

COO

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY COO Winner
Forward P/E 7.4627 15.625 XRAY
PEG Ratio 0.746 0.7269 COO
Revenue Growth -4.1% 7.9% COO
Earnings Growth 15.2% 26.9% COO
Tradestie Score 57.2/100 44.0/100 XRAY
Profit Margin -15.0% 5.6% COO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% COO 1M: +8.5% · 3M: +21.3%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

COO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.4% over 20 days), RSI 61

RSI (14): 60.9 · Price: $76.22

Fundamentals Snapshot

Metric XRAY COO
Market Cap
Forward P/E 7.2 15.3
Trailing P/E 63.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin 0.1% 0.0%
EPS -2.71 1.20
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.